Neuroprotective role of Fisetin in Alzheimer's disease: An overview of potential mechanism and clinical findings
Publisher
Apex Publishing
Reference36 articles.
1. 1. Walsh DM, Selkoe DJ. Amyloid β-protein and beyond: the path forward in Alzheimer's disease. Curr Opin Neurobiol. 2020;61:116-24.
2. 2. Janelidze S, Mattsson N, Palmqvist S, Smith R, Beach TG, Serrano GE, et al. Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia. Nat Med. 2020;26(3):379-86.
3. 3. Mayeux R, Schupf N. Blood-based biomarkers for Alzheimer's disease: plasma Aβ40 and Aβ42, and genetic variants. Neurobiol Aging. 2011;32 Suppl 1(Suppl 1):S10-9.
4. 4. Olsson B, Blennow K, Zetterberg H. The clinical value of fluid biomarkers for dementia diagnosis - Authors' reply. Lancet Neurol. 2016;15(12):1204-5.
5. 5. Uhlén M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardinoglu A, et al. Proteomics. Tissue-based map of the human proteome. Science. 2015;347(6220):1260419.